±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 401  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

23010402

¾èÖú¹ó±ö (ÖøÃûдÊÖ)

[ÇóÖú] ·­ÒëÇóÖú

Geometric mean BIBW 2992 plasma concentration¨Ctime profiles after single andmultiple dosing are shown in Figure 1. No deviation from dose-proportional behavior was observed over the evaluated dose range. Across doses, the terminal half-life of BIBW2992 ranged between 21.3 to 27.7 hours on day 1 and 22.3 to 67.0 hours on day 27. Steady-state was reached after 7 days of initiating
continuous BIBW 2992 dosing, with no evidence of further drug
accumulation or decrease through subsequent cycles. The poor association between apparent total body clearance and both weight and
body-surface area justified the fixed oral dosing of BIBW 2992 (Appendix Fig A2, online only). Table 3 summarizes the PK parameters of
BIBW 2992 on days 1 and 27 (steady-state) after single and multiple
doses, and Appendix Table A2 (online only) presents the PK param-
eters of drug under fed and fasted conditions. High-fat food intake
before single oral BIBW 2992 doses of 40 mg/d significantly altered
and decreased drug disposition.

» ²ÂÄãϲ»¶

¶þÊ®Äêǰ̫С£¬¶þÊ®ÄêºóÌ«ÀÏ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

alvarohao

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
sltmac(½ð±Ò+1): 2011-11-16 11:06:56
23010402(½ð±Ò+5, ·­ÒëEPI+1): лл~ 2011-11-16 17:27:59
ͼ1ÏÔʾÁ˸øÒ©µ¥¼ÁÁ¿ºÍ¶à¼ÁÁ¿ºóµÄBIBW2992(°¢·¨ÌæÄá)Ѫ½¬Å¨¶ÈµÄ¼¸ºÎƽ¾ùÖµÓëʱ¼äµÄ¹ØÏµÍ¼¡£ÔÚËùÆÀ¹ÀµÄ¼ÁÁ¿·¶Î§ÄÚûÓз¢ÏÖ¼ÁÁ¿ÓÐÆ«Àë±ÈÀý¹ØÏµµÄÐÐΪ¡£ÔÚËùÓмÁÁ¿ÖУ¬BIBW2992µÄ°ëË¥ÆÚÔÚµÚÒ»ÌìΪ21.3µ½27.7Сʱ£¬ÔÚµÚ27ÌìΪ22.3µ½67.0Сʱ¡£ÔÚ¿ªÊ¼Á¬Ðø¸øÒ©BIBW2992ºó7Ìì´ïµ½Îȶ¨×´Ì¬£¬ÔÚ½ÓÏÂÀ´µÄÖÜÆÚÖÐûÓнøÒ»²½µÄ»ýÀÛ»ò¼õÉÙ¡£Í¨¹ýÃ÷ÏÔµÄÈ«ÉíÇå³ýÂÊÓëÌåÖØºÍÌå±íÃæ»ýÖ®¼ä΢ÈõµÄ¹ØÏµµ÷ÕûÁËBIBW2992µÄ¹Ì¶¨¿Ú·þ¼ÁÁ¿£¨¸½Â¼Í¼A2£¬Ö»ÔÚÏßÌṩ£©¡£±í3×ܽáÁËÔÚ¸øÒ©BIBW2992µ¥¼ÁÁ¿ºÍ¶à¼ÁÁ¿ºóµÚÒ»Ììµ½µÚ27Ì죨Îȶ¨×´Ì¬£©µÄPK²ÎÊý£¬²¢ÇÒ¸½Â¼±íA2£¨Ö»ÔÚÏßÌṩ£©¸ø³öÁËÔÚÒûʳºÍ¿Õ¸¹Ìõ¼þÏÂÒ©ÎïµÄPK²ÎÊý¡£ÔÚ¿Ú·þBIBW2992µÄ40mg/d£¨ºÁ¿Ë/Ì죩µ¥¼ÁÁ¿Ö®Ç°ÉãÈ¡¸ßÖ¬·¾Ê³Î»áÃ÷ÏԵĸıäºÍÏ÷ÈõÒ©Îï´¦Öá£
ÇóŒ?„“У¬„îÖ¾ˆD?Š£¡
2Â¥2011-11-16 10:21:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ 23010402 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 277¹¤¿ÆÇóµ÷¼Á +10 1915668 2026-04-04 11/550 2026-04-06 23:53 by ÐÄæÂÒâ±±
[¿¼ÑÐ] Ò»Ö¾Ô¸ÉϺ£º£Ñó´óѧ083200ʳƷѧ˶£¬Çóµ÷¼Á£¬½ÓÊÜÆäËûרҵ +9 whatÕÅ 2026-04-01 10/500 2026-04-06 22:15 by qlm5820
[¿¼ÑÐ] 22408 331·ÖÇóµ÷¼Á +4 y__1 2026-04-06 4/200 2026-04-06 17:26 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] Ò»Ö¾Ô¸°²»Õij211 0703»¯Ñ§×Ü·Ö339Çóµ÷¼Á +7 Íí·ç²»Íí 2026-04-04 7/350 2026-04-06 14:06 by houyaoxu
[¿¼ÑÐ] Çóµ÷¼Á +10 chenxrlkx 2026-04-05 10/500 2026-04-06 11:31 by Öí»á·É
[¿¼ÑÐ] ÉúÎïÓëÒ½Ò©086000µ÷¼ÁÒ»Ö¾Ô¸Î÷±±Å©ÁÖ320·Ö +3 ÃÀÃÀŮʿ 2026-04-03 3/150 2026-04-05 21:55 by ѧԱ8dgXkO
[¿¼ÑÐ] 086000ÉúÎïÓëÒ½Ò©298µ÷¼ÁÇóÖú +9 ÔªÔªÇàÇà 2026-03-31 12/600 2026-04-05 21:03 by ѧԱ8dgXkO
[¿¼ÑÐ] ²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á +10 ¹þ¹þ¹þ¶ì¹þ¹þ¹þ 2026-04-04 10/500 2026-04-05 18:51 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ¹¤¿Æ08-»úеר˶-Çóµ÷¼Á +3 À×Å··ÉÌß 2026-04-02 3/150 2026-04-05 18:49 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 329Çóµ÷¼Á +17 miaodesi 2026-04-02 20/1000 2026-04-05 18:33 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ÉúÎ﹤³ÌÇóµ÷¼Á +6 ϲ»¶»¹ÊDz»¸ÊÐÄ 2026-04-05 6/300 2026-04-05 10:28 by ÌÆãå¶ù
[¿¼ÑÐ] 292·Ö£¬²ÄÁÏÓ뻯¹¤£¬ÉêÇëµ÷¼Á +22 ³ÌÇçÖ® 2026-04-01 26/1300 2026-04-04 22:03 by hemengdong
[¿¼ÑÐ] 277Çóµ÷¼Á +4 12A3 2026-04-02 5/250 2026-04-04 20:28 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Çóµ÷¼Á +3 ffyyu 2026-04-02 3/150 2026-04-04 19:03 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 326·ÖÇóµ÷¼Á +3 ÓÚÊǺõÄØ 2026-04-01 5/250 2026-04-03 14:23 by ÓÚÊǺõÄØ
[¿¼ÑÐ] 315·Ö 085602 Çóµ÷¼Á +15 26¿¼ÑÐÉϰ¶°æ26 2026-04-02 15/750 2026-04-03 12:45 by xingguangj
[¿¼ÑÐ] 08¿ªÍ·¿´¹ýÀ´£¡£¡£¡ +4 wwwwffffff 2026-03-31 6/300 2026-04-02 11:42 by ¾ùÖµ»Ø¹é
[¿¼ÑÐ] 354Çóµ÷¼Á +4 lxb598 2026-03-31 5/250 2026-04-02 09:55 by Jaylen.
[¿¼ÑÐ] 339Çóµ÷¼Á +5 zjjkt 2026-03-31 5/250 2026-04-01 09:18 by JourneyLucky
[¿¼ÑÐ] ½­ËÕËÕ±±¸ßУ³ÏÑûµ÷¼Áͬѧ +3 zzll406 2026-03-31 3/150 2026-03-31 16:54 by ¼°Ê±ÐÐÀÖfan
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û